NMRA
Neumora Therapeutics, Inc.
$1.83
-5.67%
2026-05-08
About Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in Phase 1b clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-861 and NMRA-898, a M4 muscarinic receptor positive allosteric modulators (PAMs) for schizophrenia and other neuropsychiatric disorders. In addition, the company's preclinical phase product includes NMRA-GCase, an activator program for the treatment of Parkinson's Disease; NMRA-CK1d, a casein kinase 1 isoform delta (CK1d) inhibitor program for Amyotrophic Lateral Sclerosis; and NMRA-215 a brain-penetrant oral NLRP3 inhibitor for the treatment of obesity. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Key Fundamentals
Forward P/E
-2.10
EPS (TTM)
$-1.33
ROE
-121.2%
Profit Margin
0.0%
Debt/Equity
52.96
Price/Book
3.16
Beta
3.05
Market Cap
$344.4M
Avg Volume (10D)
1.6M
Recent Breakout Signals
No recent breakout signals detected for NMRA.
Recent Price Range (60 Days)
60D High
$3.65
60D Low
$1.75
Avg Volume
1.3M
Latest Close
$1.83
Get breakout alerts for NMRA
Sign up for Breakout Scanner to receive daily notifications when NMRA triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Neumora Therapeutics, Inc. (NMRA) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors NMRA daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. NMRA operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.